Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2686–2700 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5068 USP9X Gene Mental Retardation, X-linked Type 99 Genetic Test This test identifies genetic variants in the USP9X gene associated with X-linked mental retardation type 99.	Peripheral whole blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number variants (CNVs) in the USP9X gene"] Parameters [] Preparation ["No fasting required"] Indications ["Confirmation of genetic aetiology in patients with unexplained intellectual disability", "Personalised care", "Accurate recurrence risk assessment", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: F78 Clinical summary This test identifies genetic variants in the USP9X gene associated with X-linked mental retardation type 99.
TEST-4509 UVSSA Gene UV-Sensitive Syndrome Type 3 Genetic Test This test identifies pathogenic variants in the UVSSA gene associated with UV-sensitive syndrome type 3.	Blood, Extracted DNA, or One Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the UVSSA gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of UV-sensitive syndrome type 3", "Family history of UV-sensitive syndrome type 3"] Measurement technique Confirm with laboratory Codes LOINC: 95821-3 ICD-10: Q82.8, L56.8 Clinical summary This test identifies pathogenic variants in the UVSSA gene associated with UV-sensitive syndrome type 3.
TEST-5702 VAMP1 Gene Spastic Ataxia Type 1, Autosomal Dominant Genetic Test This test identifies pathogenic variants within the VAMP1 gene associated with Autosomal Dominant Spastic Ataxia Type 1.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VAMP1 gene sequence", "Single nucleotide variants (SNVs)", "Insertions", "Deletions", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of Autosomal Dominant Spastic Ataxia Type 1", "Family history of Spastic Ataxia Type 1", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants within the VAMP1 gene associated with Autosomal Dominant Spastic Ataxia Type 1.
TEST-3790 VAPB Gene Amyotrophic Lateral Sclerosis Type 8 (ALS8) Genetic Test This test detects pathogenic variants in the VAPB gene associated with autosomal dominant amyotrophic lateral sclerosis type 8.	Whole Blood (EDTA)	14-21 Business Days (3-4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VAPB gene"] Parameters [] Preparation [] Indications ["Family history of amyotrophic lateral sclerosis", "Early-onset motor neuron disease", "Known VAPB variant in the family"] Measurement technique Confirm with laboratory Codes LOINC: 59027-5 ICD-10: G12.21 Clinical summary This test detects pathogenic variants in the VAPB gene associated with autosomal dominant amyotrophic lateral sclerosis type 8.
TEST-6247 VARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 20 Genetic Test This test identifies pathogenic variants in the VARS2 gene, which are associated with combined oxidative phosphorylation deficiency type 20.	Whole Blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VARS2 gene", "Copy Number Variants (CNVs) in VARS2"] Parameters [] Preparation [] Indications ["Suspected combined oxidative phosphorylation deficiency type 20 (COXPD20)", "Infantile onset encephalopathy with seizures and lactic acidosis"] Measurement technique Confirm with laboratory Codes LOINC: 95209-3 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the VARS2 gene, which are associated with combined oxidative phosphorylation deficiency type 20.
TEST-4323 VCL Gene Dilated Cardiomyopathy Type 1W Next-Generation Sequencing (NGS) Genetic Test This test evaluates the VCL gene for pathogenic variants associated with dilated cardiomyopathy type 1W.	Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VCL gene", "Copy number variants (CNVs) in the VCL gene"] Parameters [] Preparation ["Clinical genetic counselling session prior to sample collection", "Detailed family pedigree documentation"] Indications ["Diagnosis of dilated cardiomyopathy type 1W", "Genetic risk assessment for cardiomyopathy", "Family screening for VCL-related cardiomyopathy"] Measurement technique Confirm with laboratory Codes LOINC: 93239-3 ICD-10: I42.0 Clinical summary This test evaluates the VCL gene for pathogenic variants associated with dilated cardiomyopathy type 1W.
TEST-3774 VCP Gene Amyotrophic Lateral Sclerosis Type 14 Genetic Test This test identifies pathogenic variants in the VCP gene associated with autosomal dominant amyotrophic lateral sclerosis type 14.	Peripheral whole blood (EDTA)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in VCP gene", "Point mutations", "Small indels", "Copy number variations"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected diagnosis of Amyotrophic Lateral Sclerosis Type 14", "Genetic counselling for families with ALS-14", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 97934-0 ICD-10: G12.21, G12.29 Clinical summary This test identifies pathogenic variants in the VCP gene associated with autosomal dominant amyotrophic lateral sclerosis type 14.
TEST-4372 VDAC1 Gene Mitochondrial Encephalopathy Genetic Test This test identifies pathogenic variants in the VDAC1 gene, which are associated with mitochondrial encephalopathy.	Whole Blood (EDTA tube, 3–5 mL) or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VDAC1 gene", "Single nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation ["A genetic counselling session is required.", "Provide a detailed clinical history including neurological symptom onset, seizure semiology, and prior biochemical or imaging results.", "Document a three-generation pedigree.", "Obtain informed consent."] Indications ["Patients with unexplained neurological regression", "Patients with treatment-resistant seizures", "Patients with multisystem mitochondrial symptoms", "At-risk family members undergoing cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 93306-2 ICD-10: G31.81 Clinical summary This test identifies pathogenic variants in the VDAC1 gene, which are associated with mitochondrial encephalopathy.
TEST-4574 VDR Gene Rickets, Vitamin D-Resistant, Type 2A Genetic Test This diagnostic test evaluates the entire coding region of the VDR gene for pathogenic variants associated with hereditary vitamin D-resistant rickets type 2A.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VDR gene mutations (missense, indel, CNV)", "Pathogenic variants associated with VDDR2A"] Parameters [] Preparation ["No specific fasting required", "No specific medication or diet restrictions"] Indications ["Diagnosis of hereditary vitamin D-resistant rickets type 2A (VDDR2A)", "Patients with skeletal deformities unresponsive to vitamin D", "Patients with alopecia and rickets", "Family history suggestive of autosomal recessive inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 93277-8 ICD-10: E83.31 Clinical summary This diagnostic test evaluates the entire coding region of the VDR gene for pathogenic variants associated with hereditary vitamin D-resistant rickets type 2A.
TEST-5972 VEGFA Gene Genetic Test for Microvascular Complications of Diabetes Type 1 This test evaluates pathogenic variants in the VEGFA gene associated with increased risk for microvascular complications in type 1 diabetes.	Whole blood (EDTA tube), extracted DNA, or FTA card spot	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VEGFA gene pathogenic variants", "Risk for diabetic retinopathy", "Risk for diabetic nephropathy", "Risk for diabetic neuropathy"] Parameters [] Preparation [] Indications ["Type 1 diabetes", "Risk assessment for microvascular complications"] Measurement technique Confirm with laboratory Codes LOINC: 81256-6 ICD-10: E10.40 Clinical summary This test evaluates pathogenic variants in the VEGFA gene associated with increased risk for microvascular complications in type 1 diabetes.
TEST-176 Vertebrate Genome De Novo Assembly and Annotation (Illumina) Test This test performs de novo assembly and annotation of a vertebrate genome using Illumina sequencing.	Peripheral whole blood	8 weeks	45,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Complete genome sequence", "Structural and functional annotation"] Parameters [] Preparation ["Avoid anticoagulants 48 hours before blood draw", "Avoid antiplatelet agents 48 hours before blood draw", "Avoid high-dose fish oil 48 hours before blood draw"] Indications ["Rare disease research", "Pharmacogenomics", "Conservation genomics"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z13.89 Clinical summary This test performs de novo assembly and annotation of a vertebrate genome using Illumina sequencing.
TEST-1886 VHL Gene (von Hippel-Lindau Syndrome) Genetic Test This test evaluates the VHL gene for germline mutations associated with von Hippel-Lindau syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VHL gene mutations", "Germline genetic variants"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of any medications or recent transfusions"] Indications ["Individuals with a personal or family history suggestive of von Hippel-Lindau syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q85.8 Clinical summary This test evaluates the VHL gene for germline mutations associated with von Hippel-Lindau syndrome.
TEST-3964 VIPAS39 Gene Genetic Test for Arthrogryposis, Renal Dysfunction, and Cholestasis Type 2 This diagnostic test evaluates the VIPAS39 gene for pathogenic variants associated with Arthrogryposis-Renal Dysfunction-Cholestasis (ARCS) type 2.	Peripheral whole blood; buccal swab as alternative	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VIPAS39 gene", "Presence of mutations causing ARCS type 2"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "≥ 99.9%"}, {"name": "Methodology", "reference_range": "Next Generation Sequencing (NGS)"}] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions or transplants"] Indications ["Suspected diagnosis of ARCS type 2", "Familial variant screening", "Research purposes"] Measurement technique Confirm with laboratory Codes LOINC: 94041-0 ICD-10: Q87.8 Clinical summary This diagnostic test evaluates the VIPAS39 gene for pathogenic variants associated with Arthrogryposis-Renal Dysfunction-Cholestasis (ARCS) type 2.
TEST-6188 VKORC1 Gene Coumarin Resistance Genetic Test This test evaluates genetic variants in the VKORC1 gene that affect sensitivity to coumarin anticoagulants like warfarin.	Peripheral whole blood (3–5 mL in EDTA tube), extracted DNA, or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VKORC1 gene variants", "Coumarin anticoagulant sensitivity"] Parameters [] Preparation ["No specific preparation required", "Do not stop warfarin prior to sample collection"] Indications ["Patients requiring long-term anticoagulation", "History of coumarin resistance", "Adverse reactions to standard warfarin dosing"] Measurement technique Confirm with laboratory Codes LOINC: 93957-5 ICD-10: Z13.89, Z79.01 Clinical summary This test evaluates genetic variants in the VKORC1 gene that affect sensitivity to coumarin anticoagulants like warfarin.
TEST-3976 VLDLR Gene: Cerebellar Hypoplasia & Mental Retardation with or Without Quadrupedal Locomotion Test This test analyzes the VLDLR gene for pathogenic variants associated with specific neurodevelopmental disorders.	Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VLDLR gene", "Copy Number Variations (CNV) in the VLDLR gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion ( Indications ["Suspected autosomal recessive cerebellar hypoplasia", "Suspected intellectual disability with relevant clinical features", "Family history of VLDLR-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94133-1 ICD-10: G11.8, F78.9, Z15.09 Clinical summary This test analyzes the VLDLR gene for pathogenic variants associated with specific neurodevelopmental disorders.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories